Related Experiment Video
Updated: Dec 1, 2025

Intravenous Endotoxin Challenge in Healthy Humans: An Experimental Platform to Investigate and Modulate Systemic Inflammation
Published on: May 16, 2016
Evaluating Ceftriaxone 80 mg/kg Administration by Rapid Intravenous Infusion-A Clinical Service Evaluation
Sanjay Patel1,2, Helen Green1, Jacqueline Gray1
1From the Department of Paediatric Immunology & Infectious Diseases.
Insights
Shortening ceftriaxone infusions to 10 minutes in pediatric ambulatory care is safe and feasible. This practice improves patient flow and parent satisfaction, benefiting healthcare services.
Area of Science:
- Pediatric pharmacology
- Ambulatory care services
- Antibiotic administration
Background:
- Medication infusion speed significantly impacts pediatric ambulatory care workload and patient throughput.
- Current guidelines vary regarding ceftriaxone infusion times, with some allowing 10-minute infusions and others recommending longer durations (e.g., 30 minutes).
Purpose of the Study:
- To evaluate the clinical feasibility, safety, and parent satisfaction of 10-minute ceftriaxone infusions (≥50 mg/kg) in a pediatric setting.
- To assess the potential impact of shorter infusion times on patient flow in ambulatory services.
Main Methods:
- Formal service evaluation conducted at a large UK pediatric hospital.
- Implementation of 10-minute infusion practice for ceftriaxone at doses ≥50 mg/kg.
- Assessment of clinical feasibility, safety parameters, and parent satisfaction.
Main Results:
- Demonstrated clinical feasibility and safety of 10-minute ceftriaxone infusions for prescribed doses ≥50 mg/kg.
- Achieved high levels of parent satisfaction with the shortened infusion time.
- Indicated potential for improved patient flow within ambulatory services.
Conclusions:
- 10-minute ceftriaxone infusions (≥50 mg/kg) are clinically feasible and safe in pediatric ambulatory care.
- This practice enhances patient flow and parent satisfaction.
- The findings support wider adoption to optimize antibiotic administration in pediatric settings.
Abstract:
In pediatric ambulatory care, the speed of medication infusion can have major impact on healthcare staff workload and the number of children able to be treated by services designed to reduce inpatient length of stay. In many regions of the world, local and supraregional guidelines allow ceftriaxone infusions of ≥50 mg/kg in infants and children up to 12 years of age to be given over 10 minutes. The generic European summary of product characteristics for ceftriaxone does not state a specific infusion time for this dose range, although 1 manufacturers' summary of product characteristics in the United Kingdom states a 30-minute minimum infusion time. We conducted a formal service evaluation of a change in practice at a large UK pediatric children's hospital and demonstrated the clinical feasibility, safety, and high parent satisfaction of 10-minute ceftriaxone infusions for prescribed doses ≥50 mg/kg. This approach can improve patient flow within hospital-based ambulatory services as well as by community nursing teams administering antibiotics at home.
Related Concept Videos
Dosage Interval and Administration Route: Determination Methods
Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence
Drug Delivery: Parenteral Route
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
Routes of Drug Administration: Parenteral
The intravenous route (IV) of drug administration can be further categorized into two types. The bolus injection administers the entire dose rapidly, while an intravenous infusion slowly delivers smaller doses steadily.
The IV route is often...
Drug Accumulation During Multiple Dosing: Intermittent IV Infusions
Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations

